Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Schick

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Targeted Oncology|June 6, 2017
Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant CetuximabJulien Roman, Gurvan Dissaux, Maelenn Gouillou, et al.
Frontiers in Oncology|July 31, 2018
Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 StatusHind Hafsi, Magnus T Dillon, Holly E Barker, et al.
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Medical Physics|May 19, 2021
Statistical harmonization can improve the development of a multicenter CT-based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancersIngrid Masson, Ronrick Da-Ano, François Lucia, et al.
Acta Oncologica (Stockholm, Sweden)|October 7, 2017
Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrenceOsman El Kabbaj, Philippe Robin, David Bourhis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network studyUlrike Schick, Yasmin Bolukbasi, Juliette Thariat, et al.
Clinical Genitourinary Cancer|January 19, 2023
PSMA-11 PET/CT for Detection of Recurrent Prostate Cancer in Patients With Negative Choline PET/CTFanny Pinot, Romain Le Pennec, Ronan Abgral, et al.
Journal of Personalized Medicine|June 2, 2021
Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical CancerFrançois Lucia, Vincent Bourbonne, Dimitris Visvikis, et al.
Radiation Oncology (London, England)|May 24, 2019
Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trialFlorence Legouté, René-Jean Bensadoun, Valérie Seegers, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Prospective four years of evaluation of erectile function after low-dose-rate prostate brachytherapy using baseline IIEF-5 > 16Nadja Schoentgen, Julien Marolleau, Francky Delage, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Targeted Oncology|June 6, 2017
Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant CetuximabJulien Roman, Gurvan Dissaux, Maelenn Gouillou, et al.
Frontiers in Oncology|July 31, 2018
Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 StatusHind Hafsi, Magnus T Dillon, Holly E Barker, et al.
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Medical Physics|May 19, 2021
Statistical harmonization can improve the development of a multicenter CT-based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancersIngrid Masson, Ronrick Da-Ano, François Lucia, et al.
Acta Oncologica (Stockholm, Sweden)|October 7, 2017
Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrenceOsman El Kabbaj, Philippe Robin, David Bourhis, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network studyUlrike Schick, Yasmin Bolukbasi, Juliette Thariat, et al.
Clinical Genitourinary Cancer|January 19, 2023
PSMA-11 PET/CT for Detection of Recurrent Prostate Cancer in Patients With Negative Choline PET/CTFanny Pinot, Romain Le Pennec, Ronan Abgral, et al.
Journal of Personalized Medicine|June 2, 2021
Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical CancerFrançois Lucia, Vincent Bourbonne, Dimitris Visvikis, et al.
Radiation Oncology (London, England)|May 24, 2019
Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trialFlorence Legouté, René-Jean Bensadoun, Valérie Seegers, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Prospective four years of evaluation of erectile function after low-dose-rate prostate brachytherapy using baseline IIEF-5 > 16Nadja Schoentgen, Julien Marolleau, Francky Delage, et al.
Pageof 15